February 13: Breast Implant Illness

$35.00

Date:
Monday, February 13, 2023

Time:
0900 PT | 1000 MT | 1100 CT/SK | 1200 ET | 1300 AT

Duration:
120 minutes including a Q&A

Includes:
• A certificate of completion
• The live webinar event if registering prior to commencement
• The on-demand recording to watch at your convenience
• A handout in PDF format for viewing or self-printing

See below for the outline, speaker biography, and more.

Share This!
Download a PDF poster to print and post in your unit, department, or office! (Opens in new tab)

Description

Date:
Monday, February 13, 2023

Time:
0900 PT | 1000 MT | 1100 CT/SK | 1200 ET | 1300 AT

Duration:
120 minutes including a Q&A

Includes:
• A certificate of completion
• The live webinar event if registering prior to commencement
• The on-demand recording to watch at your convenience
• A handout in PDF format for viewing or self-printing

Objectives:
 At the end of the session, participants will:
1. Be able to identify what Breast Implant Illness is.
2. Understand  what  ASIA (Autoimmune/Auto-inflammatory Syndromes Induced by Adjuvants) is.
3. Understand the current research data that exists regarding Breast Implant Illness
4. Identify what are the risk factors for Breast Implant Illness
5. Discuss potential treatments for Breast implant Illness

Description:
Breast Implants are one of the most frequently performed cosmetic procedures in Canada each year. Breast implant illness (BII) is a term that refers to a range of symptoms that can develop after undergoing reconstruction or cosmetic augmentation with breast implants. BII isn’t well understood, but appears to be related to an autoimmune reaction to the implants. Patients can suffer from a number of confounding and frustrating symptoms, as they struggle to identify the cause. BII can occur with any type of breast implant, including silicone gel-filled, saline-filled, smooth surface, textured surface, round, or teardrop-shaped implants. Join our expert Dr. Jill Schofield who will discuss our current understanding of BII, the constellation of symptoms, and what the most current research indicates. She’ll also discuss risk factors for BII and potential treatments.

Who Should Attend?:
• Women’s Health Practitioners, Staff in Breast and Breast Imaging Clinics
• Staff in Primary Care, Chronic Disease & Auto-Immune Clinic Settings
• Nurses in Cosmetic Surgery Practises, Surgical Suite Nurses
• Maternal Child Nurses and Lactation Consultants
• Medical-Surgical Nurses
• Educators and Managers

Dr. Jill R. Schofield, MD is the Director of Center for Multisystem Disease in Denver, CO and Associate Clinical Professor at the University of Colorado. She completed her residency in internal medicine at the Johns Hopkins Hospital and two years of training in multi-specialty autoimmune disease and thrombosis at the University of Colorado.  In 2013, she described the association of autonomic disorders in antiphospholipid syndrome, which is a condition in which the immune system mistakenly creates antibodies that attack tissues in the body.  She was the recipient of the Dysautonomia Support Network Patient’s Choice Game Changer Award in 2019 for her work studying immunoglobulin therapy in autoimmune dysautonomia.  Her primary areas of interest are antiphospholipid syndrome and the emerging fields of autoimmune dysautonomia and mast cell activation syndrome. She works with patients with Breast Implant Illness, and specializes in tailoring treatment specific to each client’s symptoms and wishes.